The effect of whole body vibration on patients with diabetic sarcopenia

Investigating the effect of whole body vibration on muscle mass, biomechanical parameters and metabolic factors in diabetic patients with sarcopenia

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT20201128049511N6

Enrollment

Registered

2024-01-16

Start date

2024-01-20

Completion date

Unknown

Last updated

2025-07-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Condition 1: Sarcopenia. Condition 2: Type 2 diabetes. Sarcopenia Type 2 diabetes mellitus

Interventions

Intervention 1: Intervention group: The intervention consists of 12 weeks of whole body vibration for individuals with diabetic sarcopenia. In the first session, after registering the basic informatio

Eligibility

Sex/Gender

All

Age

60 Years to 80 Years

Inclusion criteria

Inclusion criteria: At least 6 months history of diabetes Diagnosis of sarcopenia in people with diabetes Score less than 13 on Michigan Neuropathy Screening Instrument

Exclusion criteria

Exclusion criteria: Having thyroid disorders GFR score above 30 History of acute ischemia such as infarction in less than 3 months History of falling in the past year Taking drugs and supplements that have known effects on the neuromuscular system (such as corticosteroids)

Design outcomes

Primary

Measure	Time frame
Ground Reaction Force Parameters. Timepoint: Before and after 12 weeks of intervention. Method of measurement: Force plate device.;Quality of Life Index. Timepoint: Before and after 12 weeks of interventions. Method of measurement: SarQoL questionnaire.;Parameters of the body sway. Timepoint: ??? ? ??? ?? 12 ???? ??????. Method of measurement: Force plate.;Body mass parameters. Timepoint: ??? ? ??? ?? 12 ???? ??????. Method of measurement: DXA.	—

Measure

Time frame

Ground Reaction Force Parameters. Timepoint: Before and after 12 weeks of intervention. Method of measurement: Force plate device.;Quality of Life Index. Timepoint: Before and after 12 weeks of interventions. Method of measurement: SarQoL questionnaire.;Parameters of the body sway. Timepoint: ??? ? ??? ?? 12 ???? ??????. Method of measurement: Force plate.;Body mass parameters. Timepoint: ??? ? ??? ?? 12 ???? ??????. Method of measurement: DXA.

—

Secondary

Measure	Time frame
Muscle strength. Timepoint: Before and after 12 weeks of intervention. Method of measurement: Dynamometer.;Lipid profile. Timepoint: Before and after 12 weeks of intervention. Method of measurement: Blood test.;Fasting blood sugar(FBS). Timepoint: Before and after 12 weeks of intervention. Method of measurement: Blood test.;Glycated hemoglobin (A1C). Timepoint: Before and after 12 weeks of intervention. Method of measurement: Blood test.;Inflammation factors. Timepoint: Before and after 12 weeks of intervention. Method of measurement: Blood test.	—

Measure

Time frame

Muscle strength. Timepoint: Before and after 12 weeks of intervention. Method of measurement: Dynamometer.;Lipid profile. Timepoint: Before and after 12 weeks of intervention. Method of measurement: Blood test.;Fasting blood sugar(FBS). Timepoint: Before and after 12 weeks of intervention. Method of measurement: Blood test.;Glycated hemoglobin (A1C). Timepoint: Before and after 12 weeks of intervention. Method of measurement: Blood test.;Inflammation factors. Timepoint: Before and after 12 weeks of intervention. Method of measurement: Blood test.

—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMotahare Ababaf Behbahani

The University of Tarbiat Modares

m.behbahani@modares.ac.ir+98 21 8288 5053

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026